University of Dundee

Latest News

September 2016

  • 30 Sep 2016

    Complementary and collaborative research from the research groups of Professor Julian Blow and Professor Tim Newman has been published in two sister papers in Proceedings of the National Academy of Sciences (PNAS). The work focuses on experimental and theoretical evidence that unreplicated DNA can pass through mitosis for resolution in the following cell cycle.

  • 23 Sep 2016

    The University of Dundee has been named Scottish University of the Year in The Times and Sunday Times Good University Guide for a second consecutive year. Dundee has been hailed for excellent teaching quality and student experience, being placed in the top ten in the UK for both key measures in the Good University Guide analysis. The Guide also noted the strength of research at the University and the institution’s economic, social and cultural impact.

  • 20 Sep 2016

    The University of Dundee has announced renewed funding of more than £7million from three of the world’s leading pharmaceutical companies to support its Division of Signal Transduction Therapy (DSTT). Pharmaceutical giants Boehringer Ingelheim, GlaxoSmithKline and Merck will provide support of £7.2 million until 2020, enabling scientists at Dundee to continue their fundamental research in multiple therapeutic areas, including cancer, arthritis, lupus, hypertension and Parkinson’s disease. This new round of funding secures 38 posts at Dundee for the next four years.

  • 19 Sep 2016

    Nanotechnology is engineering at an unimaginably small scale, that of individual molecules. Nature has led the way with this, constructing complex structures and functioning machines inside living cells, and scientists are taking a lead from this to engineer molecular-scale objects using natural molecules as building blocks. These could have a variety of potential functions, the most promising of which is the precise, targeted delivery of drug molecules. This is perhaps the real-life equivalent of the old science-fiction movie Fantastic Voyage (1966), or a step in that direction.

  • 19 Sep 2016

    Lack of a genetic transformation system has hindered plant-parasitic nematology for some time. Recently, Plant Sciences independent investigator Dr Sebastian Eves-van den Akker brought the greatest minds in the field together to discuss this problem, after being awarded a BBSRC international workshop grant. The workshop was held in parallel with the European Society of Nematologists conference in Braga, Portugal, and comprised two days of stimulating and challenging discussions.

  • 14 Sep 2016

    Malaria remains one of the world’s leading causes of mortality in developing countries. Last year alone, it killed more than 400,000 people, mostly young children. This week in ACS Central Science, an international consortium of researchers, including scientists at the University of Dundee, unveils the mechanics and findings of a unique “open science” project for malaria drug discovery that has been five years in the making.

  • 13 Sep 2016

    David Foley has been shortlisted for the KickStart Digital Entrepreneur Award in the Converge Challenge, Scotland’s entrepreneurial development programme, for his proposed company, Elemental Therapeutics. The idea is to develop a new technology to tackle the challenge of oral drug delivery.

  • 09 Sep 2016

    In the last 10-15 years stem cells have been catapulted from a relatively obscure research topic to the international limelight. Hardly a week goes by without some news story about a “ground breaking discovery” or “exciting new therapy” involving stem cells. Are these cells really as exciting as people think? What are they, where do they come from and how are they used in modern medicine? Why are private stem cell clinics springing up all over the world, and can they really deliver on their promises? What about the ethics of stem cell research?  

  • 08 Sep 2016

    The cattle disease nagana, also called African animal trypanosomiasis, caused by the parasites Trypanosoma vivax and Trypanosoma congolense, affects huge swathes of sub-Saharan Africa, and the T. vivax disease has also spread to South America. With around 60 million cattle at risk from the disease, which causes muscle wasting and death, the socio-economic impacts of T. vivax infections in livestock are profound.